SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Research

Read more breaking news

 

 

Omega-3 foods linked to Lou Gehrig disease risk reduction

By Anne Bruce , 21-Aug-2014
Last updated on 21-Aug-2014 at 10:32 GMT2014-08-21T10:32:41Z

Omega-3 from plant and marine sources linked to reduced risk of developing Amyotrophic lateral sclerosis, also known as Lou Gehrig disease
Omega-3 from plant and marine sources linked to reduced risk of developing Amyotrophic lateral sclerosis, also known as Lou Gehrig disease

Eating foods high Omega 3 fatty acids may reduce the risk of developing the incurable neurodegenerative disease Amyotrophic lateral sclerosis (ALS) a study suggests.

In the study, published in July in JAMA Neurol and conducted by Harvard researchers, the 20% of consumers who had highest levels of omega-3 fatty acid in their diet were a third less likely develop the fatal disease compared with the 20% who ate the lowest amount of omega-3s.

Amyotrophic lateral sclerosis (ALS), known in America as Lou Gehrig's disease, is a rapidly progressive neurological disease that attacks the nerve cells responsible for controlling voluntary muscles. It is one of the most common neuromuscular diseases worldwide, and people of all races and ethnic backgrounds are affected. Renowned physicist Professor Stephen Hawking is a sufferer of the condition.

The study, led by Kathryn Fitzgerald at Harvard School of Public Health, examined the association of ω-3 and ω-6 PUFA consumption and ALS risk in an analysis of data gathered from more than one million people who had participated in five previously published studies.

They knew that diet-derived long-chain polyunsaturated fatty acids (PUFAs) are incorporated in brain lipids and modulate oxidative and inflammatory processes and could thus affect ALS risk and progression, although there was little data available.

PUFA consumption

Researchers documented 995 ALS cases during follow-up, which ranged from nine to 24 years. A greater ω-3 PUFA intake was associated with a reduced risk for ALS. Consuming both α-linolenic acid (ALA, which can be found in plant sources and nuts) and marine ω-3 PUFAs contributed to this association. Intake of ω-6 PUFAs was not associated with ALS risk.

Diet was assessed through questionnaires. For men, median ω-3 PUFA intake ranged from 1.40 to 1.85 grams(g)/day(d) and median ω-6 PUFA intake ranged from 11.82 to 15.73 g/d. For women, median ω-3 intake ranged from 1.14 to 1.43 g/d and median ω-6 PUFA intake ranged from 8.94 to 12.01 g/d.

"Overall, the results of our large prospective cohort study suggest that individuals with higher dietary intakes of total ω-3 PUFA and ALA have a reduced risk for ALS,” the paper said.

Further research, possibly including biomarkers of PUFA intake, should be pursued to confirm these findings and to determine whether high ω-3 PUFA intake could be beneficial in individuals with ALS, the researchers suggest.

The research was supported by grants from the National Institute of Neurological Diseases and Stroke, the National Cancer Institute and the ALS Therapy Alliance Foundation.

Michael Swash, M.D., of the Royal London Hospital, England, said: "Fitzgerald and colleagues suggest that the fatty acid composition of cell plasma membranes, which could be measured in red cell membranes, might be important in modulating oxidative stress responses, excitotoxicity and inflammation, all factors that have been implicated in ALS and other neurodegenerative conditions."

"As a note of caution and in contrast to their results, the authors note that in a mouse model of ALS pretreatment with high doses of eicosapentanoic acid, a long-chain ω-3 PUFA, accelerated disease progression," Swash added.

Source:
JAMA Neurol.
doi:10.1001/jamaneurol.2014.1214
‘Dietary ω-3 Polyunsaturated Fatty Acid Intake and Risk for Amyotrophic Lateral Sclerosis’
Authors: Kathryn C. Fitzgerald, MSc; Éilis J. O’Reilly, ScD; Guido J. Falcone, MD; et al.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars